EKF Diagnostics (LON:EKF – Get Free Report) released its quarterly earnings data on Tuesday. The company reported GBX 0.54 earnings per share (EPS) for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 4.86% and a return on equity of 3.58%.
EKF Diagnostics Trading Up 1.2%
Shares of EKF Diagnostics stock traded up GBX 0.30 during mid-day trading on Friday, hitting GBX 26. The stock had a trading volume of 7,569,254 shares, compared to its average volume of 366,829. The firm has a 50-day moving average of GBX 25.45 and a two-hundred day moving average of GBX 25.51. The firm has a market cap of £111.32 million, a P/E ratio of 55.32 and a beta of 0.50. The company has a quick ratio of 1.77, a current ratio of 4.72 and a debt-to-equity ratio of 2.09. EKF Diagnostics has a 12-month low of GBX 22 and a 12-month high of GBX 31.70.
About EKF Diagnostics
? Point-of-Care analysers in the key areas of Hematology and Diabetes
? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Read More
- Five stocks we like better than EKF Diagnostics
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
